Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

The United States opioid epidemic.

Lyden J, Binswanger IA.

Semin Perinatol. 2019 Jan 14. pii: S0146-0005(19)30001-1. doi: 10.1053/j.semperi.2019.01.001. [Epub ahead of print] Review.

PMID:
30711195
2.

Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings.

Kline-Simon AH, Stumbo SP, Campbell CI, Binswanger IA, Weisner C, Haller IV, Hechter RC, Ahmedani BK, Lapham GT, Loree AM, Sterling SA, Yarborough BJH.

Subst Abus. 2019 Jan 31:1-7. doi: 10.1080/08897077.2018.1547812. [Epub ahead of print]

PMID:
30702983
3.

Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems.

Loree AM, Yeh HH, Satre DD, Kline-Simon AH, Jo H Yarborough B, Haller IV, Campbell CI, Lapham GT, Hechter RC, Binswanger IA, Weisner C, Ahmedani BK.

Subst Abus. 2019 Jan 25:1-7. doi: 10.1080/08897077.2018.1545727. [Epub ahead of print]

PMID:
30681938
4.

Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems.

Campbell CI, Weisner C, Binswanger IA, Lapham GT, Ahmedani BK, Yarborough BJH, Haller IV, Altschuler A, Hechter RC, Loree AM, Kline-Simon AH.

Subst Abus. 2019 Jan 24:1-7. doi: 10.1080/08897077.2018.1545729. [Epub ahead of print]

PMID:
30676931
5.

Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015.

Weisner C, Campbell CI, Altschuler A, Yarborough BJH, Lapham GT, Binswanger IA, Hechter RC, Ahmedani BK, Haller IV, Sterling SA, McCarty D, Satre DD, Kline-Simon AH.

Subst Abus. 2019 Jan 24:1-11. doi: 10.1080/08897077.2018.1545728. [Epub ahead of print]

PMID:
30676915
6.

The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders.

Binswanger IA, Carroll NM, Ahmedani BK, Campbell CI, Haller IV, Hechter RC, McNeely J, Yarborough BJH, Kline-Simon AH, Satre DD, Weisner C, Lapham GT.

Subst Abus. 2019 Jan 24:1-10. doi: 10.1080/08897077.2018.1545726. [Epub ahead of print]

PMID:
30676892
7.

The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.

Lapham GT, Campbell CI, Yarborough BJH, Hechter RC, Ahmedani BK, Haller IV, Kline-Simon AH, Satre DD, Loree AM, Weisner C, Binswanger IA.

Subst Abus. 2019 Jan 18:1-10. doi: 10.1080/08897077.2018.1544964. [Epub ahead of print]

PMID:
30657438
8.

Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use.

Winkelman TNA, Chang VW, Binswanger IA.

JAMA Netw Open. 2018 Jul 6;1(3):e180558. doi: 10.1001/jamanetworkopen.2018.0558.

9.

Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary Care.

Binswanger IA, Joseph N, Hanratty R, Gardner EM, Durfee J, Narwaney KJ, Breslin K, Mueller SR, Glanz JM.

Mayo Clin Proc Innov Qual Outcomes. 2018 Nov 2;2(4):309-316. doi: 10.1016/j.mayocpiqo.2018.09.005. eCollection 2018 Dec.

10.

Prenatal Marijuana Use by Self-Report and Umbilical Cord Sampling in a State With Marijuana Legalization.

Metz TD, Silver RM, McMillin GA, Allshouse AA, Jensen TL, Mansfield C, Heard K, Kinney GL, Wymore E, Binswanger IA.

Obstet Gynecol. 2019 Jan;133(1):98-104. doi: 10.1097/AOG.0000000000003028.

PMID:
30531577
11.

Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science.

Finlay AK, Binswanger IA, Timko C, Smelson D, Stimmel MA, Yu M, Bowe T, Harris AHS.

J Subst Abuse Treat. 2018 Dec;95:43-47. doi: 10.1016/j.jsat.2018.09.006. Epub 2018 Oct 2.

PMID:
30352669
12.

Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone.

Binswanger IA, Glanz JM.

Drug Saf. 2018 Oct;41(10):979-980. doi: 10.1007/s40264-018-0705-8. No abstract available.

PMID:
30073490
13.

Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime.

Molero Y, Zetterqvist J, Binswanger IA, Hellner C, Larsson H, Fazel S.

Am J Psychiatry. 2018 Oct 1;175(10):970-978. doi: 10.1176/appi.ajp.2018.17101112. Epub 2018 Aug 2.

PMID:
30068260
14.

Preventing Opioid Overdose in the Clinic and Hospital: Analgesia and Opioid Antagonists.

Peglow SL, Binswanger IA.

Med Clin North Am. 2018 Jul;102(4):621-634. doi: 10.1016/j.mcna.2018.02.005. Review.

PMID:
29933819
15.

Tobacco Use Among People Who Have Been in Prison: Relapse and Factors Associated with Trying to Quit.

Frank MR, Blumhagen R, Weitzenkamp D, Mueller SR, Beaty B, Min SJ, Binswanger IA.

J Smok Cessat. 2017 Jun;12(2):76-85. doi: 10.1017/jsc.2016.3. Epub 2016 Mar 16.

16.

Prediction of Future Chronic Opioid Use Among Hospitalized Patients.

Calcaterra SL, Scarbro S, Hull ML, Forber AD, Binswanger IA, Colborn KL.

J Gen Intern Med. 2018 Jun;33(6):898-905. doi: 10.1007/s11606-018-4335-8. Epub 2018 Feb 5.

PMID:
29404943
17.

Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy.

Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA.

J Gen Intern Med. 2018 Oct;33(10):1646-1653. doi: 10.1007/s11606-017-4288-3. Epub 2018 Jan 29.

PMID:
29380216
18.

Factors associated with physician self-efficacy in mental illness management and team-based care.

Loeb DF, Leister E, Ludman E, Binswanger IA, Crane L, Dickinson M, Kline DM, deGruy FV, Nease D, Bayliss EA.

Gen Hosp Psychiatry. 2018 Jan - Feb;50:111-118. doi: 10.1016/j.genhosppsych.2017.11.003. Epub 2017 Nov 11. No abstract available.

19.

"Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications.

Kennedy LC, Binswanger IA, Mueller SR, Levy C, Matlock DD, Calcaterra SL, Koester S, Frank JW.

Pain Med. 2018 Nov 1;19(11):2201-2211. doi: 10.1093/pm/pnx276.

PMID:
29126138
20.
21.

Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose?

Koester S, Mueller SR, Raville L, Langegger S, Binswanger IA.

Int J Drug Policy. 2017 Oct;48:115-124. doi: 10.1016/j.drugpo.2017.06.008. Epub 2017 Jul 19.

22.

Ascertainment of Vital Status Among People With Criminal Justice Involvement Using Department of Corrections Records, the US National Death Index, and Social Security Master Death Files.

Binswanger IA, Morenoff JD, Chilcote CA, Harding DJ.

Am J Epidemiol. 2017 May 15;185(10):982-985. doi: 10.1093/aje/kww221. No abstract available.

23.

A Qualitative Study of Hospitalists' Perceptions of Patient Satisfaction Metrics on Pain Management.

Calcaterra SL, Drabkin AD, Doyle R, Leslie SE, Binswanger IA, Frank JW, Reich JA, Koester S.

Hosp Top. 2017 Jan-Mar;95(1):18-26. doi: 10.1080/00185868.2017.1300479.

24.

Health Conditions and Racial Differences Among Justice-Involved Adolescents, 2009 to 2014.

Winkelman TNA, Frank JW, Binswanger IA, Pinals DA.

Acad Pediatr. 2017 Sep - Oct;17(7):723-731. doi: 10.1016/j.acap.2017.03.003. Epub 2017 Mar 12.

PMID:
28300655
25.

Development and initial validation of primary care provider mental illness management and team-based care self-efficacy scales.

Loeb DF, Crane LA, Leister E, Bayliss EA, Ludman E, Binswanger IA, Kline DM, Smith M, deGruy FV, Nease DE, Dickinson LM.

Gen Hosp Psychiatry. 2017 Mar - Apr;45:44-50. doi: 10.1016/j.genhosppsych.2016.12.005. Epub 2016 Dec 22.

26.

Maternal Deaths From Suicide and Overdose in Colorado, 2004-2012.

Metz TD, Rovner P, Hoffman MC, Allshouse AA, Beckwith KM, Binswanger IA.

Obstet Gynecol. 2016 Dec;128(6):1233-1240.

27.

Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain.

Mueller SR, Koester S, Glanz JM, Gardner EM, Binswanger IA.

J Gen Intern Med. 2017 Mar;32(3):277-283. doi: 10.1007/s11606-016-3895-8. Epub 2016 Oct 31.

28.

Epidemiology of Infectious Disease-Related Death After Release from Prison, Washington State, United States, and Queensland, Australia: A Cohort Study.

Binswanger IA, Blatchford PJ, Forsyth SJ, Stern MF, Kinner SA.

Public Health Rep. 2016 Jul-Aug;131(4):574-82.

29.

Patients' Perspectives on Tapering of Chronic Opioid Therapy: A Qualitative Study.

Frank JW, Levy C, Matlock DD, Calcaterra SL, Mueller SR, Koester S, Binswanger IA.

Pain Med. 2016 Oct;17(10):1838-1847. Epub 2016 May 20.

30.

The hospitalist perspective on opioid prescribing: A qualitative analysis.

Calcaterra SL, Drabkin AD, Leslie SE, Doyle R, Koester S, Frank JW, Reich JA, Binswanger IA.

J Hosp Med. 2016 Aug;11(8):536-42. doi: 10.1002/jhm.2602. Epub 2016 May 9.

31.

Primary care providers' experiences caring for complex patients in primary care: a qualitative study.

Loeb DF, Bayliss EA, Candrian C, deGruy FV, Binswanger IA.

BMC Fam Pract. 2016 Mar 22;17:34. doi: 10.1186/s12875-016-0433-z.

32.

Sources of Prescription Opioids for Nonmedical Use.

Bartels K, Binswanger IA, Hopfer CJ.

J Addict Med. 2016 Mar-Apr;10(2):134. doi: 10.1097/ADM.0000000000000192. No abstract available.

33.

Opioid Use and Storage Patterns by Patients after Hospital Discharge following Surgery.

Bartels K, Mayes LM, Dingmann C, Bullard KJ, Hopfer CJ, Binswanger IA.

PLoS One. 2016 Jan 29;11(1):e0147972. doi: 10.1371/journal.pone.0147972. eCollection 2016.

34.

From risk reduction to implementation: Addressing the opioid epidemic and continued challenges to our field.

Binswanger IA, Gordon AJ.

Subst Abus. 2016;37(1):1-3. doi: 10.1080/08897077.2015.1134152. No abstract available.

PMID:
26820257
35.

Naloxone Administration in US Emergency Departments, 2000-2011.

Frank JW, Levy C, Calcaterra SL, Hoppe JA, Binswanger IA.

J Med Toxicol. 2016 Jun;12(2):148-56. doi: 10.1007/s13181-015-0525-5.

36.

Non-medical use of prescription pain medications and increased emergency department utilization: Results of a national survey.

Frank JW, Binswanger IA, Calcaterra SL, Brenner LA, Levy C.

Drug Alcohol Depend. 2015 Dec 1;157:150-7. doi: 10.1016/j.drugalcdep.2015.10.027. Epub 2015 Oct 29.

37.

Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use.

Calcaterra SL, Yamashita TE, Min SJ, Keniston A, Frank JW, Binswanger IA.

J Gen Intern Med. 2016 May;31(5):478-85. doi: 10.1007/s11606-015-3539-4.

38.

Clinical risk factors for death after release from prison in Washington State: a nested case-control study.

Binswanger IA, Stern MF, Yamashita TE, Mueller SR, Baggett TP, Blatchford PJ.

Addiction. 2016 Mar;111(3):499-510.

39.

Primary care physician insights into a typology of the complex patient in primary care.

Loeb DF, Binswanger IA, Candrian C, Bayliss EA.

Ann Fam Med. 2015 Sep;13(5):451-5. doi: 10.1370/afm.1840.

40.

Immunization Coverage Among Juvenile Justice Detainees.

Gaskin GL, Glanz JM, Binswanger IA, Anoshiravani A.

J Correct Health Care. 2015 Jul;21(3):265-75. doi: 10.1177/0885066615587790.

PMID:
26084948
41.

Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.

Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM.

J Gen Intern Med. 2015 Dec;30(12):1837-44. doi: 10.1007/s11606-015-3394-3.

42.

A comparison of liver disease mortality with HIV and overdose mortality among Georgia prisoners and releasees: a 2-decade cohort study of prisoners incarcerated in 1991.

Spaulding AC, Sharma A, Messina LC, Zlotorzynska M, Miller L, Binswanger IA.

Am J Public Health. 2015 May;105(5):e51-7. doi: 10.2105/AJPH.2014.302546. Epub 2015 Mar 19.

43.

A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.

Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA.

Subst Abus. 2015;36(2):240-53. doi: 10.1080/08897077.2015.1010032. Epub 2015 Mar 16. Review.

44.

Sex differences in mental health and substance use disorders and treatment entry among justice-involved Veterans in the Veterans Health Administration.

Finlay AK, Binswanger IA, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, Timko C, Blodgett JC, Harris AH, Asch SM, Frayne S.

Med Care. 2015 Apr;53(4 Suppl 1):S105-11. doi: 10.1097/MLR.0000000000000271.

45.

The Association Between Stimulant, Opioid, and Multiple Drug Use on Behavioral Health Care Utilization in a Safety-Net Health System.

Calcaterra SL, Keniston A, Blum J, Crume T, Binswanger IA.

Subst Abus. 2015;36(4):407-12. doi: 10.1080/08897077.2014.996697. Epub 2015 Mar 4.

46.

Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice.

Binswanger IA, Glanz JM.

Subst Abus. 2015;36(2):141-3. doi: 10.1080/08897077.2014.991058. Epub 2015 Feb 11.

47.

Commentary on Forsyth et al. (2014): Subgroup differences in post-release mortality-implications for access to diverse and effective treatments.

Binswanger IA.

Addiction. 2014 Oct;109(10):1684-5. doi: 10.1111/add.12687. No abstract available.

PMID:
25163712
48.

Prison tobacco control policies and deaths from smoking in United States prisons: population based retrospective analysis.

Binswanger IA, Carson EA, Krueger PM, Mueller SR, Steiner JF, Sabol WJ.

BMJ. 2014 Aug 5;349:g4542. doi: 10.1136/bmj.g4542.

49.

A patient navigation intervention for drug-involved former prison inmates.

Binswanger IA, Whitley E, Haffey PR, Mueller SR, Min SJ.

Subst Abus. 2015;36(1):34-41. doi: 10.1080/08897077.2014.932320. Epub 2014 Jun 24.

50.

Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response.

Broyles LM, Binswanger IA, Jenkins JA, Finnell DS, Faseru B, Cavaiola A, Pugatch M, Gordon AJ.

Subst Abus. 2014;35(3):217-21. doi: 10.1080/08897077.2014.930372.

Supplemental Content

Loading ...
Support Center